Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailMaintaining cognitive function starts early in life
Leist, Anja UL

Speeches/Talks (2016)

Detailed reference viewed: 53 (1 UL)
Full Text
Peer Reviewed
See detailMaking sense of big data in health research: Towards an EU action plan.
Auffray, Charles; Balling, Rudi UL; Barroso, Ines et al

in Genome medicine (2016), 8(1), 71

Medicine and healthcare are undergoing profound changes. Whole-genome sequencing and high-resolution imaging technologies are key drivers of this rapid and crucial transformation. Technological innovation ... [more ▼]

Medicine and healthcare are undergoing profound changes. Whole-genome sequencing and high-resolution imaging technologies are key drivers of this rapid and crucial transformation. Technological innovation combined with automation and miniaturization has triggered an explosion in data production that will soon reach exabyte proportions. How are we going to deal with this exponential increase in data production? The potential of "big data" for improving health is enormous but, at the same time, we face a wide range of challenges to overcome urgently. Europe is very proud of its cultural diversity; however, exploitation of the data made available through advances in genomic medicine, imaging, and a wide range of mobile health applications or connected devices is hampered by numerous historical, technical, legal, and political barriers. European health systems and databases are diverse and fragmented. There is a lack of harmonization of data formats, processing, analysis, and data transfer, which leads to incompatibilities and lost opportunities. Legal frameworks for data sharing are evolving. Clinicians, researchers, and citizens need improved methods, tools, and training to generate, analyze, and query data effectively. Addressing these barriers will contribute to creating the European Single Market for health, which will improve health and healthcare for all Europeans. [less ▲]

Detailed reference viewed: 267 (7 UL)
Full Text
See detailLes malades chroniques veulent avoir des rapports nouveaux « plus jeunes » avec les professionnels de santé….
Baumann, Michèle UL

Article for general public (2018)

« S’appuyer sur Nos expériences liées à notre maladie, aux soins reçus, c’est faire entendre Notre vécu et reconnaitre Notre savoir à Nous ». L’équipe du Pr Michèle BAUMANN est allée à la rencontre de ... [more ▼]

« S’appuyer sur Nos expériences liées à notre maladie, aux soins reçus, c’est faire entendre Notre vécu et reconnaitre Notre savoir à Nous ». L’équipe du Pr Michèle BAUMANN est allée à la rencontre de personnes (dyalisées, victimes d’un Accident Vasculaire Cérébral, de cancer du sein, de maladies rares, …) pour qu’elles nous parlent des relations qu’elles ont avec les professionnels et les équipes (infirmiers, médecins, spécialistes, etc.). Dans le cadre d’un projet INTERREG (cofinancé FEDER) concernant le Luxembourg, mais aussi les pays frontaliers de la Grande-Région, les membres d’associations ont exprimé leurs attentes sur la façon dont ils souhaiteraient avoir des relations de PARTENAIRES. « S’intéresser à mes questions car pour moi c’est survivre… m’impliquer dans les soins pour que j’apprenne … partager et échanger les informations qui me concernent… et surtout m’investir dans le processus …pour que je me sente partie prenante dans les décisions qui doivent être prises… » sont des demandes d’une époque nouvelle. Les discours de ces personnes en cours d’analyses, avec l’appui d’Angela ODERO doctorante, permettront de comprendre les points forts à discuter pour mettre en œuvre des réseaux de porte-parole, des formations pour les patients et professionnels, etc. Les personnes des associations qui veulent aussi s’exprimer en groupe, doivent nous contacter. Michèle Baumann, professeure en sociologie médicale et santé publique à l’IRSEI, à l’Université du Luxembourg, a été nommée en octobre 2018 par la Commission Européenne, experte indépendante pour le Luxembourg sur les soins de santé de longue durée et membre de l’European Social Policy Network (ESPN). [less ▲]

Detailed reference viewed: 36 (1 UL)
Full Text
Peer Reviewed
See detailThe mammalian Ste20-like kinase 2 (Mst2) modulates stress-induced cardiac hypertrophy.
Zi, Min; Maqsood, Arfa; Prehar, Sukhpal et al

in The Journal of biological chemistry (2014), 289(35), 24275-88

The Hippo signaling pathway has recently moved to center stage in cardiac research because of its key role in cardiomyocyte proliferation and regeneration of the embryonic and newborn heart. However, its ... [more ▼]

The Hippo signaling pathway has recently moved to center stage in cardiac research because of its key role in cardiomyocyte proliferation and regeneration of the embryonic and newborn heart. However, its role in the adult heart is incompletely understood. We investigate here the role of mammalian Ste20-like kinase 2 (Mst2), one of the central regulators of this pathway. Mst2(-/-) mice showed no alteration in cardiomyocyte proliferation. However, Mst2(-/-) mice exhibited a significant reduction of hypertrophy and fibrosis in response to pressure overload. Consistently, overexpression of MST2 in neonatal rat cardiomyocytes significantly enhanced phenylephrine-induced cellular hypertrophy. Mechanistically, Mst2 positively modulated the prohypertrophic Raf1-ERK1/2 pathway. However, activation of the downstream effectors of the Hippo pathway (Yes-associated protein) was not affected by Mst2 ablation. An initial genetic study in mitral valve prolapse patients revealed an association between a polymorphism in the human MST2 gene and adverse cardiac remodeling. These results reveal a novel role of Mst2 in stress-dependent cardiac hypertrophy and remodeling in the adult mouse and likely human heart. [less ▲]

Detailed reference viewed: 155 (0 UL)
Full Text
Peer Reviewed
See detailManagement of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
Descamps, O. S.; Tenoutasse, S.; Stephenne, X. et al

in Atherosclerosis (2011), 218(2), 272-280

Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual from birth onwards to severe hypercholesterolemia with the development of early cardiovascular disease, a ... [more ▼]

Since heterozygous familial hypercholesterolemia (HeFH) is a disease that exposes the individual from birth onwards to severe hypercholesterolemia with the development of early cardiovascular disease, a clear consensus on the management of this disease in young patients is necessary. In Belgium, a panel of paediatricians, specialists in (adult) lipid management, general practitioners and representatives of the FH patient organization agreed on the following common recommendations.1.Screening for HeFH should be performed only in children older than 2 years when HeFH has been identified or is suspected (based on a genetic test or clinical criteria) in one parent.2.The diagnostic procedure includes, as a first step, the establishment of a clear diagnosis of HeFH in one of the parents. If this precondition is satisfied, a low-density-lipoprotein cholesterol (LDL-C) level above 3.5mmol/L (135mg/dL) in the suspected child is predictive for differentiating affected from non-affected children.3.A low saturated fat and low cholesterol diet should be started after 2 years, under the supervision of a dietician or nutritionist.4.The pharmacological treatment, using statins as first line drugs, should usually be started after 10 years if LDL-C levels remain above 5mmol/L (190mg/dL), or above 4mmol/L (160mg/dL) in the presence of a causative mutation, a family history of early cardiovascular disease or severe risk factors. The objective is to reduce LDL-C by at least 30% between 10 and 14 years and, thereafter, to reach LDL-C levels of less than 3.4mmol/L (130mg/dL).Conclusion: The aim of this consensus statement is to achieve more consistent management in the identification and treatment of children with HeFH in Belgium. © 2011 Elsevier Ireland Ltd. [less ▲]

Detailed reference viewed: 99 (0 UL)
Full Text
See detailMarche et attention sélective chez les personnes âgées
Cornu, Véronique UL; Steinmetz, Jean-Paul; Federspiel, Carine

Poster (2014, May)

Un lien entre troubles de la marche, chutes et fonction cognitives (fonctions exécutives et attention), chez les personnes âgées peut être considéré comme établi. En ce qui concerne les paramètres de la ... [more ▼]

Un lien entre troubles de la marche, chutes et fonction cognitives (fonctions exécutives et attention), chez les personnes âgées peut être considéré comme établi. En ce qui concerne les paramètres de la marche, une variabilité du pas élevée et un ralentissement de la vitesse de marche sous condition de double tâche, sont des indicateurs sensibles permettant d’évaluer le risque de chute. La présente étude s´est intéressée aux différences de ces paramètres de marche en fonction de la performance dans un test d´attention sélective. L´échantillon est composé de 33 personnes âgées en long séjour (âge moyen : 83.7, écart-type : 6.2). L´analyse de la marche a été effectué à l´aide du système Gaitrite® qui permet de mesurer e.a. la vitesse, la variabilité de la durée du cycle de marche et la variabilité de la longueur du cycle de marche. L´attention sélective a été mesurée avec un test d´attention sélective adapté aux personnes âgées. Les personnes ont été regroupées sur la base de leur performance dans ce test (temps requis et erreurs commises) afin d´obtenir deux groupes : un groupe plus performant et un groupe moins performant. On a pu observer des différences de marche en fonction de l´attention sélective. Plus précisément, dans le groupe moins performant considérant les erreurs commises lors du test, la variabilité de la longueur du cycle de marche sous condition double tâche était sifnificativement supérieure à celle du groupe plus performant (U = 175.0, p < .05). Ces résultats mettent en évidence les différences dans les paramètres de marche, et le risque de chute associé, en fonction de la capacité d´attention sélective chez les personnes âgées. [less ▲]

Detailed reference viewed: 141 (11 UL)
Full Text
Peer Reviewed
See detailThe marine biodiscovery pipeline and ocean medicines of tomorrow
Crawford, Alexander Dettmar UL; Jaspars, Marcel; De Pascale, Donatella et al

in Journal of the Marine Biological Association of the United Kingdom (2016), 96(01), 151-158

Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in ... [more ▼]

Marine organisms possess the capacity to produce a variety of unique and biologically potent natural products for treating human diseases, many of which are currently commercially available or are in advanced clinical trials. Here we provide a short review on progress in the field and discuss a case study of an EU-funded project, PharmaSea, which aims to discover novel products for the treatment of infections, inflammation and neurodegenerative diseases. Research in this sector is opening new doors for harnessing the potential of marine natural products with pharmaceutical properties. [less ▲]

Detailed reference viewed: 418 (2 UL)
Full Text
See detailMathematical Histopathology and Systems Pharmacology of Melanoma
Albrecht, Marco UL

Doctoral thesis (2019)

Treated metastatic melanoma often becomes resistant and relapses whereby resistance mechanisms can be found at the level of biochemical, histological, and pharmacological data. By using this data in a ... [more ▼]

Treated metastatic melanoma often becomes resistant and relapses whereby resistance mechanisms can be found at the level of biochemical, histological, and pharmacological data. By using this data in a mathematical form, an integrative understanding of tumour progression can be gained that reveal the functionality of more complex and hidden recurrence mechanisms. The aims of this thesis were - to investigate how a new engineering concept on tumour growth, based on porous media theory, can be leveraged to support medicine and cancer biology research, - to identify suitable tests for cancer growth model validation, - to study how elements of biochemical cancer pathways are linked to the elements of physical growth, and - to establish a pharmacokinetics module for the melanoma cancer drug dabrafenib. The studied engineering concept is qualitatively suitable to represent late-stage metastatic melanoma in irregular fibrous tissue types, whereby all equations are tested for biological relevance and parametrisation. The framework allows modelling of tissue-specific growth, and the thesis shows that the simulated tumour can shift between compact growth with ECM displacement and invasive growth with ECM circumvention as a consequence of cell plasticity/viscosity change. This is unique among continuous models of tumour growth. However, the investigation also shows that the pressure-saturation relationships are not biologically motivated and can be replaced by a swelling polymer model which captures the water absorbing effect of glycans. The thesis addresses a biologically and computationally reasonable strategy to validate the tumour growth model as complete as possible. A suitable way to validate a part of the tumour growth model is using time course data of spheroid growth in hydrogels of different stiffness values. Spheroids generated from the LU451 melanoma cell line mainly grow due to ECM degradation, have a time-variant growth rate increasing with gel rigidity, and the confined environment renders the melanoma cell line drug-resistant upon dabrafenib dose escalation. This setting reveals the interplay between mechanical and biochemical development over time. The dependency between biological elements of cancer pathways and the mechanical elements of the engineering concept on tumour growth were clarified. Therefore, the literature on mechanoregulation has been reviewed and serves as a computational link between systems biology and physical oncology. Finally, the thesis provides preliminary steps and a concept toward a serious interdisciplinary methodology to understand tumour growth, although this cannot be considered a final model for any of the known melanoma growth settings. Additionally, the thesis provides a novel quantitative systems pharmacology approach to consider liver-enzyme-induction and drug-drug-interaction. The finding is that the potent dabrafenib metabolite desmethyl-dabrafenib accumulates with consequential efficacy loss in a confined tumour environment. [less ▲]

Detailed reference viewed: 196 (9 UL)
Full Text
Peer Reviewed
See detailMeasurement of plasma membrane calcium-calmodulin-dependent ATPase (PMCA) activity.
Mohamed, Tamer M. A.; Baudoin-Stanley, Florence M.; Abou-Leisa, Riham et al

in Methods in molecular biology (Clifton, N.J.) (2010), 637

The plasma membrane calcium-calmodulin-dependent ATPase (PMCA) is a calcium-extruding enzymatic pump that ejects calcium from the cytoplasm to the extracellular compartment. Although in excitable cells ... [more ▼]

The plasma membrane calcium-calmodulin-dependent ATPase (PMCA) is a calcium-extruding enzymatic pump that ejects calcium from the cytoplasm to the extracellular compartment. Although in excitable cells such as skeletal and cardiac muscle cells PMCA has been shown to play only a minor role in regulating global intracellular calcium concentration, increasing evidence points to an important role for PMCA in signal transduction, in particular in the nitric oxide signaling pathway. Moreover, recent evidence has shown the functional importance of PMCA in mediating cardiac contractility and vascular tone. Here we describe a method in determining PMCA activity in the microsomal membrane preparation from cultured cells that overexpress specific isoform of PMCA by using modified coupled enzyme assay. [less ▲]

Detailed reference viewed: 110 (0 UL)
Peer Reviewed
See detailMeasurement of the nalgesic efects of aspirin with a new experimantal algesimetric procedure
Fortser, Clemens; Anton, Fernand UL; Reeh, Peter-Werner et al

in Pain (1988), 32(2), 215-222

Detailed reference viewed: 27 (0 UL)
Full Text
Peer Reviewed
See detailMeasuring sex and gender identity in a cross-national adolescent population survey: Perspectives of adolescent health experts from 44 countries
Költő, András; Heinz, Andreas UL; Moreno-Maldonado, Concepcion et al

in Cogent Medicine (2020, December 04)

Introduction: The Health Behaviour in School-aged Children (HBSC) is a World Health Organization collaborative cross-cultural study of adolescents aged 11–15 years, from 50 countries and regions in Europe ... [more ▼]

Introduction: The Health Behaviour in School-aged Children (HBSC) is a World Health Organization collaborative cross-cultural study of adolescents aged 11–15 years, from 50 countries and regions in Europe, North America and the former Soviet republics. Since 1983 (the first survey round), the sex/gender of the respondents have been categorised with the question “Are you a boy or a girl?”, the response options being “a boy” and “a girl”. In the light of lived experiences of young people and contemporary theoretical and empirical approaches to the measurement of sex assigned birth and gender identity, this item is contested.Research Questions: What are HBSC National Research Teams’ experiences with using this item? What is their position on any potential change or amendment of the item? Have they already made any changes? Do they see potential drawbacks and benefits in changing the item? Method: In Summer 2019, an online survey was conducted with HBSC National Teams, to under-stand member countries’ position on the measurement of sex and gender in the HBSC survey. Results: Of the 50 research teams, 44 responded to the online questionnaire. Opinions on potential changes or amendments of the item were polarised, with 19 teams (43%) not supporting any changes, 15 teams (34%) agreeing with a change, and 10 teams (23%) indicating they don’t know or not sure if changes are necessary. Various arguments were raised for and against any changes or amendments. Six national teams already implemented a change, by adding a third response option, replacing the item, or using additional items. Conclusions: The results demonstrate that the issue of sex and gender in HBSC needs to be addressed, but methodological, political and cultural implications need to be considered. The complexity of this problem makes it impossible to suggest a “one-size-fits-all” solution. [less ▲]

Detailed reference viewed: 115 (3 UL)
Full Text
Peer Reviewed
See detailMechanical strength assessment of a drilled hole in the contralateral cortex at the end of the open wedge for high tibial osteotomy.
Diffo Kaze, Arnaud UL; Maas, Stefan UL; Hoffmann, Alexander et al

in Journal of Experimental Orthopaedics (2017), 4(1),

BACKGROUND: This study aimed to investigate, by means of finite element analysis, the effect of a drill hole at the end of a horizontal osteotomy to reduce the risk of lateral cortex fracture while ... [more ▼]

BACKGROUND: This study aimed to investigate, by means of finite element analysis, the effect of a drill hole at the end of a horizontal osteotomy to reduce the risk of lateral cortex fracture while performing an opening wedge high tibial osteotomy (OWHTO). The question was whether drilling a hole relieves stress and increases the maximum correction angle without fracture of the lateral cortex depending on the ductility of the cortical bone. METHODS: Two different types of osteotomy cuts were considered; one with a drill hole (diameter 5 mm) and the other without the hole. The drill holes were located about 20 mm distally to the tibial plateau and 6 mm medially to the lateral cortex, such that the minimal thickness of the contralateral cortical bone was 5 mm. Based on finite element calculations, two approaches were used to compare the two types of osteotomy cuts considered: (1) Assessing the static strength using local stresses following the idea of the FKM-guideline, subsequently referred to as the "FKM approach" and (2) limiting the total strain during the opening of the osteotomy wedge, subsequently referred to as "strain approach". A critical opening angle leading to crack initiation in the opposite lateral cortex was determined for each approach and was defined as comparative parameter. The relation to bone aging was investigated by considering the material parameters of cortical bones from young and old subjects. RESULTS: The maximum equivalent (von-Mises) stress was smaller for the cases with a drill hole at the end of the osteotomy cut. The critical angle was approximately 1.5 times higher for the specimens with a drill hole compared to those without. This corresponds to an average increase of 50%. The calculated critical angle for all approaches is below 5°. The critical angle depends on the used approach, on patient's age and assumed ductility of the cortical bone. CONCLUSIONS: Drilling a hole at the end of the osteotomy reduces the stresses in the lateral cortex and increases the critical opening angle prior to cracking of the opposite cortex in specimen with small correction angles. But the difference from having a drill hole or not is not so significant, especially for older patients. The ductility of the cortical bone is the decisive parameter for the critical opening angle. [less ▲]

Detailed reference viewed: 847 (9 UL)
Peer Reviewed
See detail[Mechanism of action of calcium antagonists].
Stimpel, M.; Neyses, Ludwig UL

in Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis (1985), 74(19), 483-90

Detailed reference viewed: 43 (0 UL)
Peer Reviewed
See detailMechanisms of disease: An introduction to clinical sciences
Neyses, Ludwig UL; Buch, MH

in Tomlinson, H; Heagerty, AM; Weetman, AP (Eds.) et al Heart Failure (2007)

Detailed reference viewed: 53 (0 UL)
Full Text
Peer Reviewed
See detailMechanisms of estrogen receptor action in the myocardium. Rapid gene activation via the ERK1/2 pathway and serum response elements.
de Jager, T.; Pelzer, T.; Muller-Botz, S. et al

in The Journal of biological chemistry (2001), 276(30), 27873-80

We have previously shown that the myocardium is a target tissue for estrogen. Here, we have identified rapid non-nuclear estrogen effects on the expression of the early growth response gene-1 (Egr-1) in ... [more ▼]

We have previously shown that the myocardium is a target tissue for estrogen. Here, we have identified rapid non-nuclear estrogen effects on the expression of the early growth response gene-1 (Egr-1) in cardiomyocytes. Egr-1 mRNA and protein were rapidly and strongly induced by estrogen in an estrogen receptor-dependent manner via the extracellular signal-regulated kinase, ERK1/2. A promoter analysis study of a 1.2-kilobase Egr-1 promoter fragment revealed that the serum response elements (SREs) but not the estrogen response elements or AP-1 sites are responsible for Egr-1 induction by estrogen, identifying a novel mechanism of estrogen receptor-dependent gene activation in the myocardium. Both estrogen receptor-alpha and -beta induced the Egr-1 promoter via the SREs as well as an artificial promoter consisting of only five SREs in cardiomyocytes. Electrophoretic mobility shift assays showed that a protein complex containing serum response factor or an antigenically related protein was recruited to the SREs by estrogen treatment of primary cardiomyocytes. The recruitment of the protein complex was inhibited by the specific estrogen receptor antagonist ICI 182,780 as well as the MEK inhibitor PD 98059. Taken together, these results identify SREs as important promoter control elements for an estrogen receptor-dependent mechanism of gene activation in the myocardium. [less ▲]

Detailed reference viewed: 57 (0 UL)
Peer Reviewed
See detailMedizinische Eingriffe und Operationsstress
Vögele, Claus UL

in Bengel, J.; Jerusalem, M. (Eds.) Handbuch der Gesundheitspsychologie und Medizinischen Psychologie (2009)

Detailed reference viewed: 63 (0 UL)
Full Text
Peer Reviewed
See detailMedizinstudenten und ihre Berufsperspektiven - In welcher Facharztrichtung, wo und wie wollen sie arbeiten?
Heinz, Andreas UL; Jacob, Rüdiger

in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz (2012), 55(2), 245-253

This article presents selected results from a nationwide online survey in Germany asking medical students about their occupational perspectives and expectations: what kind of specialization are they ... [more ▼]

This article presents selected results from a nationwide online survey in Germany asking medical students about their occupational perspectives and expectations: what kind of specialization are they inclined to, where do they want to work, and under what conditions? We sent an email to all the students at 34 of 36 faculties of medicine, asking them to partake in the survey. Through 9 July 2010, 12,518 students answered, which is 15.7% of all 79,929 students enrolled in medicine. One central result is that general medicine—compared to the current situation — will have significant problems in recruiting young medical professionals, if the preferences of the students do not change. In addition, we found spatial disparities: students consider Berlin and Hamburg, urban areas in Southern Germany and the Ruhr Area as attractive places to work, whereas economically underdeveloped rural areas in both Eastern and Western Germany are highly unattractive. So especially So especially those regions will face the problem of recruiting a sufficient number of general practitioners. One strategy to solve this problem could be to recruit young adults for medical school from these rural locations, because there is also a clear tendency that students study close to their home and later also want to work there. [less ▲]

Detailed reference viewed: 90 (10 UL)
Full Text
Peer Reviewed
See detailMedroxyprogesterone acetate but not drospirenone ablates the protective function of 17 beta-estradiol in aldosterone salt-treated rats.
Arias-Loza, Paula Anahi; Hu, Kai; Schafer, Andreas et al

in Hypertension (2006), 48(5), 994-1001

Controversial results obtained from human and animal studies on the prevention of heart disease by estrogens and progestins warrant a better understanding of nuclear hormone receptor function and ... [more ▼]

Controversial results obtained from human and animal studies on the prevention of heart disease by estrogens and progestins warrant a better understanding of nuclear hormone receptor function and interaction. To address this issue and taking into account that effects of synthetic progestins are not only referable to action through the progesterone receptor but may also be mediated by other steroid receptors, we characterized cardiovascular function and inflammatory gene expression in aldosterone salt-treated rats on long-term administration of 17beta-estradiol, medroxyprogesterone acetate, and drospirenone, a new progestogen exhibiting antimineralocorticoid activity. The complex pattern of cardiovascular injury in ovariectomized Wistar rats induced by chronic aldosterone infusion plus a high-salt diet was significantly attenuated in sham-ovariectomized rats and by coadministration of 17beta-estradiol in ovariectomized animals after 8 weeks of continuous treatment. The beneficial role of 17beta-estradiol on blood pressure, cardiac hypertrophy, vascular osteopontin expression, perivascular fibrosis, and impaired NO-dependent relaxation of isolated aortic rings was completely abrogated by coadministration of medroxyprogesterone acetate. In contrast, drospirenone was either neutral or additive to 17beta-estradiol in protecting against aldosterone salt-induced cardiovascular injury and inflammation. The current results support the hypothesis of complex interactions among estrogen, progesterone, glucocorticoid, androgen, and mineralocorticoid receptor signaling in cardiovascular injury and inflammation. Novel progestins, such as drospirenone, confer superior effects compared with medroxyprogesterone acetate in a model of aldosterone-induced heart disease because of its antimineralocorticoid properties. [less ▲]

Detailed reference viewed: 199 (0 UL)
See detail“Melanomics”: analysis and integration of whole genomes, transcriptomes and miRNomes of primary melanoma patients
Reinsbach, Susanne; Wienecke, Anke UL; Ginolhac, Aurélien UL et al

in European Journal of Cancer (2016), 61(Suppl.1), 32

Detailed reference viewed: 284 (22 UL)